Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1995 Oct;69(10):6239-48.
doi: 10.1128/JVI.69.10.6239-6248.1995.

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1

Affiliations
Comparative Study

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1

M Girard et al. J Virol. 1995 Oct.

Abstract

The extraordinary genetic diversity of human immunodeficiency virus type 1 (HIV-1) is a major problem to overcome in the development of an effective vaccine. In the most reliable animal model of HIV-1 infection, chimpanzees were immunized with various combinations of HIV-1 antigens, which were derived primarily from the surface glycoprotein, gp160, of HIV-1 strains LAI and MN. The immunogens also included a live recombinant canarypox virus expressing a gp160-MN protein. In one experiment, two chimpanzees were immunized multiple times; one animal received antigens derived only from HIV-1LAI, and the second animal received antigens from both HIV-1LAI and HIV-1MN. In another experiment, four chimpanzees were immunized in parallel a total of five times over 18 months; two animals received purified gp160 and V3-MN peptides, whereas the other two animals received the recombinant canarypox virus and gp160. At 3 months after the final booster, all immunized and naive control chimpanzees were challenged by intravenous inoculation of HIV-1SF2; therefore, the study represented an intrasubtype B heterologous virus challenge. Virologic and serologic follow-up showed that the controls and the two chimpanzees immunized with the live recombinant canarypox virus became infected, whereas the other animals that were immunized with gp160 and V3-MN peptides were protected from infection. Evaluation of both cellular and humoral HIV-specific immune responses at the time of infectious HIV-1 challenge identified the following as possible correlates of protection: antibody titers to the V3 loop of MN and neutralizing antibody titers to HIV-1MN or HIV-1LAI, but not to HIV-1SF2. The results of this study indicate that vaccine-mediated protection against intravenous infection with heterologous HIV-1 strains of the same subtype is possible with some immunogens.

PubMed Disclaimer

References

    1. J Chromatogr. 1989 Aug 4;476:99-112 - PubMed
    1. AIDS Res Hum Retroviruses. 1995 Mar;11(3):373-81 - PubMed
    1. J Virol. 1990 Feb;64(2):864-72 - PubMed
    1. Nature. 1990 Jun 14;345(6276):622-5 - PubMed
    1. Science. 1990 Jun 8;248(4960):1234-7 - PubMed

Publication types

MeSH terms